[go: up one dir, main page]

AU2013209296A1 - Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture - Google Patents

Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture

Info

Publication number
AU2013209296A1
AU2013209296A1 AU2013209296A AU2013209296A AU2013209296A1 AU 2013209296 A1 AU2013209296 A1 AU 2013209296A1 AU 2013209296 A AU2013209296 A AU 2013209296A AU 2013209296 A AU2013209296 A AU 2013209296A AU 2013209296 A1 AU2013209296 A1 AU 2013209296A1
Authority
AU
Australia
Prior art keywords
thymodepressin
manufacture
processes
pharmaceutically acceptable
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013209296A
Inventor
Regis Leung-Toung
Blaise N'zemba
Tim Fat Tam
Yingsheng Wang
Lily Yu
Yanqing Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apotex Technologies Inc
Original Assignee
Apotex Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Technologies Inc filed Critical Apotex Technologies Inc
Publication of AU2013209296A1 publication Critical patent/AU2013209296A1/en
Abandoned legal-status Critical Current

Links

AU2013209296A 2006-12-19 2013-07-18 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture Abandoned AU2013209296A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2,571,645 2006-12-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2007335212A Division AU2007335212B2 (en) 2006-12-19 2007-12-13 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture

Publications (1)

Publication Number Publication Date
AU2013209296A1 true AU2013209296A1 (en) 2013-08-08

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113376229A (en) * 2021-05-12 2021-09-10 云南中烟工业有限责任公司 Tetracycline doped polyaniline electrode, preparation method and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113376229A (en) * 2021-05-12 2021-09-10 云南中烟工业有限责任公司 Tetracycline doped polyaniline electrode, preparation method and application thereof

Similar Documents

Publication Publication Date Title
EP2220093A4 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
ZA200906899B (en) Process for preparation of erlotinib and its pharmaceutically acceptable salts
SI2086945T1 (en) Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
WO2009084024A3 (en) A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
AU2007306104A1 (en) Hydrobenzamide derivatives as inhibitors of Hsp90
EP2039689A4 (en) Process for production of optically active 3-amino-2 -hydroxypropionic cyclopropylamide derivatives and salts thereof
IL196228A0 (en) 4-hydroxythiobenzamide derivatives of drugs
EP1968943A4 (en) An improved process for the preparation of montelukast and its pharmaceutically acceptable salts
ZA200902575B (en) Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
AU2007225022A8 (en) Non-codeine opioid analgesic process and formulations
ZA200900230B (en) 4-hydroxythiobenzamide derivatives of drugs
EP2121729A4 (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
GB0606234D0 (en) Pharmaceutically acceptable salts and polymorphic forms
EP1883619B8 (en) Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts
AU2013209296A1 (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
HK1139159A (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
ZA201000159B (en) Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof
HK1143142A (en) Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof
GB0605344D0 (en) Pharmaceutically acceptable salts and polymorphic forms
GB0609465D0 (en) Pharmaceutically acceptable salts and polymorphic forms
HK1127606A (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
HK1131991A (en) New derivatives of 5-thioxilopyranose
AU2006903527A0 (en) Methods For The Preparation Of Pharmaceutically Active Compounds in Nanoparticulate Form
HK1125947A (en) DERIVATIVES OF 18β-GLYCYRRHETINIC ACID
HK1132161A (en) Method for distribution of a drug